X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Peroxitech’s lead product, PIP-2 is delivered into the lungs to prevent the cytokine storm cascade to treat and prevent ALI. PIP-2 helps to target cytokine build up in the lungs that leads to respiratory failure with hypoxemia and tissue acidosis, regardless of etiology.
Lead Product(s): PIP-2
Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: PIP-2
Highest Development Status: PreclinicalProduct Type: Peptide
Partner/Sponsor/Collaborator: Perceptive Xontogeny Venture Fund
Deal Size: $25.0 million Upfront Cash: Undisclosed
Deal Type: Series A Financing December 13, 2022
Details:
Peroxitech’s lead product, PIP-2 is delivered into the lungs to prevent the cytokine storm cascade to treat and prevent ALI. PIP-2 helps to target cytokine build up in the lungs that leads to respiratory failure with hypoxemia and tissue acidosis, regardless of etiology.
Lead Product(s): PIP-2
Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: PIP-2
Highest Development Status: PreclinicalProduct Type: Peptide
Partner/Sponsor/Collaborator: Xontogeny, LLC
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Financing May 12, 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
